Immune to Cancer: The CRI Blog
-
CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy
The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the… -
Translating Science into Survival at the 8th Annual CICON Conference
CRI is proud to co-host the eighth annual Cancer Immunotherapy Conference (CICON) alongside the European Network for… -
10 Attractions to Visit in and around Washington, D.C. While Attending CICON24
The eighth annual CRI-ENCI Cancer Immunotherapy Conference (CICON24) kicks off on September 8 in National Harbor, Maryland…. -
2022 International Cancer Immunotherapy Conference Highlights from Day 4
The final day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) wrapped up an amazing conference… -
2022 International Cancer Immunotherapy Conference Highlights from Day 3
The third day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) focused on two relatively new… -
2022 International Cancer Immunotherapy Conference Highlights from Day 2
The second day of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22) started off by delving deeper… -
2022 International Cancer Immunotherapy Conference Highlights from Day 1
Back for the first time since the COVID-19 pandemic began, the sixth annual CRI-ENCI-AACR International Cancer Immunotherapy… -
CICON19 Day 4 Update: Metabolic Crosstalk and the Microbiome
Day 4 of CICON19 highlighted breakthroughs in our understanding of the metabolic crosstalk within the tumor microenvironment as…
-
CICON19 Day 3 Update: Vaccines and Tumor Antigens, Technology and Informatics, and the Tumor Microenvironment
Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…